about
Medical interventions for treating primary angle-closure glaucomaSystem for Rapid, Precise Modulation of Intraocular Pressure, toward Minimally-Invasive In Vivo Measurement of Intracranial PressureRelationship between the magnitude of intraocular pressure during an episode of acute elevation and retinal damage four weeks later in rats.Effects of prostaglandin analogues on aqueous humor outflow pathways.Comparison of retinal nerve fiber layer thickness in vivo and axonal transport after chronic intraocular pressure elevation in young versus older rats.Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats.1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates.Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucomaEffect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized studyAssessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomographyCircadian variation of aqueous dynamics in young healthy adults.Morphine-induced nitric oxide production in isolated, iris-ciliary bodies.Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides.Emerging drugs for ocular hypertension.Metabolism of ophthalmic timolol: new aspects of an old drug.A review of the use of latanoprost for glaucoma since its launch.The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.Applications of the water drinking test in glaucoma management.Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes.Effects of water drinking test on ocular blood flow waveform parameters: A laser speckle flowgraphy study.Intraocular pressure dynamics with prostaglandin analogs: a clinical application of the water-drinking test.Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension.Water Drinking Test: Intraocular Pressure Changes after Tube Surgery and Trabeculectomy.Measuring mental workload: ocular astigmatism aberration as a novel objective index.A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty.Comparison between intraocular pressure spikes with water loading and postural change.Topical application of 0.005% latanoprost increases episcleral venous pressure in normal dogs.Targeted Drug Delivery in the Suprachoroidal Space by Swollen Hydrogel Pushing.
P2860
Q24187443-AC86903E-A997-4339-82D9-E3A85BBEABD2Q27330167-B7FBE976-7226-4CD2-A312-BD77EACD913FQ31125980-70D908C0-D931-40EA-9861-750366F8A860Q34393424-11667B5A-30B1-49AB-B6FE-FD91F772FB96Q34682128-3A2C54FF-389B-4F9F-8AD2-734A65B70C1CQ35084563-599EF5CB-5269-4737-9E0F-9B3A8F72BA11Q36079723-72F7A6C8-8A93-47F4-8D4C-BB72BAE75E15Q36788792-E0591006-A5E1-4E4C-BAE4-1B0B814258ACQ37032753-8B61A6A4-DCC8-41A5-AE69-2789D5822472Q37325071-F240226F-6050-4D2E-B8E4-319F8D14C8F1Q37355208-B8FCCEB7-4E55-443C-ABF6-FBE4B69A914DQ37376293-7E32C6F0-F628-4417-A649-B28A4F97A18FQ37636153-9D31689A-1A87-4B61-8A8E-4781B600A922Q37847182-C6A22BE2-8DB3-46AB-BD0D-6235A2DB0047Q37850837-023BC2B9-304E-4A73-BFB8-550267EC2CC3Q37986149-258FD61D-A3DA-4D75-9A35-9D40A8DBE184Q38637048-E896E375-255C-4875-83DD-BDF16F99127DQ38977483-786D48E3-9C7A-4578-9CF7-EBE3EB14E828Q41036726-AE5626B2-2B6F-4B0A-AE8C-7E763A3E0AD4Q41105960-87F06CFC-FA1B-49AF-A10C-E18D1A4B32ABQ42389019-31D34FC3-C53E-4B8D-AFF6-5B972750A880Q43216533-987F1C64-7AA8-46E9-9F6F-AE6387D43EABQ47138922-59E40A41-B63F-4C46-863A-69093C7A2BE8Q47592716-58B754CD-BB2B-40EF-9F77-7ABDBD39826EQ50331769-43D08AF5-A409-4612-BC84-A73A0162218CQ50509698-3141F0BC-FE5E-4944-990F-9B970BBA4DF4Q51381582-5FC41730-E97D-49EE-AD92-D78900068F02Q55315376-A4BBF934-F0F5-425D-AEF1-09A688F93AF0
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Targeting outflow facility in glaucoma management.
@ast
Targeting outflow facility in glaucoma management.
@en
type
label
Targeting outflow facility in glaucoma management.
@ast
Targeting outflow facility in glaucoma management.
@en
prefLabel
Targeting outflow facility in glaucoma management.
@ast
Targeting outflow facility in glaucoma management.
@en
P1476
Targeting outflow facility in glaucoma management.
@en
P2093
Richard F Brubaker
P304
P356
10.1016/S0039-6257(03)00003-1
P478
48 Suppl 1
P577
2003-04-01T00:00:00Z